Screener
iRadimed IRMD Q2 2026 earnings
Reported July 31, 2026 · Before market open
Revenue$20.5MBeat by $116.0K
EPS$0.46Beat by $0.02
Revenue estimate$20.4M
EPS estimate$0.44
“For the third quarter of 2026, we expect revenue of $23.0 million to $24.5 million and GAAP diluted earnings per share of $0.49 to $0.54 and non-GAAP diluted earnings per share of $0.54 to $0.59. We reaffirm our guidance for the full-year 2026, expecting to report revenue of $91.0 million to $96.0 million, and GAAP diluted earnings per share of $1.90 to $2.05 and non-GAAP diluted earnings per share of $2.09 to $2.24”
Next report
Nov 2, 2026 (in a month)Revenue estimate$23.2M
EPS estimate$0.52
Valuation & ratios
Valuation
as of 09/17/26Versus estimates
Revenue
Diluted EPS
FAQ
- When did iRadimed report Q2 2026 earnings?
- iRadimed (IRMD) reported Q2 2026 earnings on July 31, 2026 before market open.
- What were iRadimed's Q2 2026 revenue and EPS?
- iRadimed reported revenue of $20.5M and eps of $0.46 for Q2 2026.
- Did iRadimed beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $20.4M by $116.0K. EPS beat the consensus estimate of $0.44 by $0.02.
- How did iRadimed's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 0.3% from $20.4M a year earlier and eps declined 6.1% from $0.49.
- Where can I find iRadimed's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-051240) and the 10-Q periodic report (0001628280-26-051402) directly on SEC EDGAR. The filing index links above go to sec.gov.
